Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation. (Q53188305)

12 May 2018

title

Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation. (English)

1 reference

12 May 2018

0 references

Sangmi Ock

1

1 reference

12 May 2018

Jihyun Ahn

2

1 reference

12 May 2018

Seok Hong Lee

3

1 reference

12 May 2018

Hongryeol Park

4

1 reference

12 May 2018

Jang Won Son

5

1 reference

12 May 2018

Jae Gyun Oh

6

1 reference

12 May 2018

Dong Kwon Yang

7

1 reference

12 May 2018

Wang Soo Lee

8

1 reference

12 May 2018

Ho-Shik Kim

9

1 reference

12 May 2018

Jaerang Rho

10

1 reference

12 May 2018

Goo Taeg Oh

11

1 reference

12 May 2018

Evan Dale Abel

12

1 reference

12 May 2018

Woo Jin Park

13

1 reference

12 May 2018

Jeong-Ki Min

14

1 reference

12 May 2018

Jaetaek Kim

15

1 reference

12 May 2018

publication date

1 February 2012

1 reference

12 May 2018

published in

Cardiovascular Research

1 reference

12 May 2018

volume

94

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

105-114

1 reference

12 May 2018

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

The role of tumor necrosis factor in the pathophysiology of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

Stress-activated cytokines and the heart: from adaptation to maladaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

Immune activation in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

Tumor necrosis factor-alpha and mortality in heart failure: a community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

The role of IL-1 in the pathogenesis of heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

Osteoprotegerin ligand: a regulator of immune responses and bone physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

Receptor Activator of Nuclear Factor κB Ligand Is a Novel Inducer of Tissue Factor in Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

The "sunshine deficit" and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

PICOT is a critical regulator of cardiac hypertrophy and cardiomyocyte contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

21 January 2018

Paget disease of bone

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

Minireview: Won't get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

Phospholipase Cgamma2 mediates RANKL-stimulated lymph node organogenesis and osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

p38 MAP Kinase Mediates Inflammatory Cytokine Induction in Cardiomyocytes and Extracellular Matrix Remodeling in Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS078

21 January 2018

Identifiers

DOI

10.1093/CVR/CVS078

1 reference

12 May 2018

1 reference

12 May 2018